Albinismo oculocutâneo tipo 1 (OCA1) descreve um grupo de albinismos oculocutâneos (OCA) relacionados à tirosina, que inclui o OCA1A, OCA1B, albinismo oculocutâneo tipo 1 de pigmentação mínima (OCA1-MP) e albinismo oculocutâneo tipo 1 sensível à temperatura (OCA1-TS).
Introdução
O que você precisa saber de cara
Albinismo oculocutâneo tipo 1 (OCA1) descreve um grupo de albinismos oculocutâneos (OCA) relacionados à tirosina, que inclui o OCA1A, OCA1B, albinismo oculocutâneo tipo 1 de pigmentação mínima (OCA1-MP) e albinismo oculocutâneo tipo 1 sensível à temperatura (OCA1-TS).
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 12 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 41 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.
This is a copper-containing oxidase that functions in the formation of pigments such as melanins and other polyphenolic compounds. Catalyzes the initial and rate limiting step in the cascade of reactions leading to melanin production from tyrosine (By similarity). In addition to hydroxylating tyrosine to DOPA (3,4-dihydroxyphenylalanine), also catalyzes the oxidation of DOPA to DOPA-quinone, and possibly the oxidation of DHI (5,6-dihydroxyindole) to indole-5,6 quinone (PubMed:28661582)
Melanosome membraneMelanosome
Albinism, oculocutaneous, 1A
An autosomal recessive disorder in which the biosynthesis of melanin pigment is absent in skin, hair, and eyes. It is characterized by complete lack of tyrosinase activity due to production of an inactive enzyme. Patients present with a life-long absence of melanin pigment after birth, and manifest increased sensitivity to ultraviolet radiation with predisposition to skin cancer. Visual anomalies include decreased acuity, nystagmus, strabismus and photophobia.
Variantes genéticas (ClinVar)
408 variantes patogênicas registradas no ClinVar.
Classificação de variantes (ClinVar)
Distribuição de 33 variantes classificadas pelo ClinVar.
Vias biológicas (Reactome)
2 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Albinismo oculocutâneo tipo 1
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
🟢 Recrutando agora
1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
Publicações mais relevantes
Insights from Computational Dynamic Active Site Mapping into Substrate Recognition and Mutation-Induced Dysfunction in Human Tyrosinase.
The ability of enzymes to recognize and process structurally diverse substrates is fundamental to metabolic flexibility and biological regulation. In melanin biosynthesis, human tyrosinase (Tyr) catalyzes the oxidation of several chemically distinct intermediates, including L-tyrosine, L-DOPA, DHICA, and DHI. Although its catalytic chemistry is well established, the structural basis of substrate selectivity and how it is altered by disease-associated mutations remains unclear. Using molecular docking and molecular dynamics simulations, we mapped the Tyr active site and identified 23 evolutionarily conserved residues that mediate multi-substrate recognition and binding. Across all substrates, binding induces coordinated conformational responses, particularly within an anchoring region (334-347) that provides electrostatic and hydrophobic steering, and a flexible gating loop (374-386) that modulates access and stabilizes bound intermediates. The OCA1B-associated P406L mutation, although distant from the catalytic core, disrupts long-range dynamic coupling and impairs loop flexibility, while 25 ClinVar-listed genetic variants at substrate-interacting residues weaken active-site organization, underscoring the sensitivity of Tyr's dynamic network to perturbation. Integrating these findings, we propose an ordered multi-substrate binding mechanism in which substrates are first guided by the anchoring region, then aligned by the universal triad, and finally refined through loop-mediated, substrate-specific contacts. Our work suggests a dynamic framework that could be useful for understanding human tyrosinase catalysis, genetic mutation impact, and future engineering strategies.
First Report of Oculocutaneous Albinism Type I Among Baka Pygmies From Cameroon.
Oculocutaneous albinism type 1 (OCA1) caused by pathogenic variants of the TYR gene is an autosomal recessive disorder of pigmentation characterized by reduced biosynthesis of melanin pigment in skin, hair, and eyes. We had the opportunity to examine five East Cameroon Baka rainforest hunter-gatherers (historically called "Pygmies") with albinism and belonging to three different families. Screening of known albinism genes revealed a homozygous missense variant in the TYR gene, NM_000372.5: c.1109T>C; p.Met370Thr. In addition, one patient was also hemizygous for a variant in GPR143, the gene involved in ocular albinism (OA1). Another patient was also heterozygous for the common African and Afro-American 2.7-kb deletion in the OCA2 gene indicating admixture of one parent with neighboring Nzimé Bantu-speaking farmers. This is the first report of the occurrence of OCA1 in African rainforest hunter-gatherers.
Quantifying functional vision in a mouse model of oculocutaneous albinism type 1.
Alterations of Photoreceptor Synaptic Ribbons in the Retina of a Human Patient With Oculocutaneous Albinism Type 1 (OCA1).
Albino (Tyrc-2J/Tyrc-2J) C57BL/6J mice carry a mutation in the tyrosinase gene and are known to display alterations of photoreceptor synaptic ribbons. In the present study, we wanted to test whether similar alterations exist in oculocutaneous albinism type 1 (OCA1), a human disease that also results from mutations in the tyrosinase gene. In the present study, we assessed the morphology of a human OCA1 retina in comparison to control human retinas. We analyzed the retina of a 35-year-old OCA1 patient by immunolabeling at light and electron microscopic levels, conventional transmission electron microscopy, and by genomic DNA sequencing of the RIBEYE/CtBP2 gene in comparison to normal human controls. The morphological analyses revealed an overall surprisingly normal appearance of the retina, except for the presence of strikingly abnormal photoreceptor synaptic ribbons. Synaptic ribbons are presynaptic specializations of the continuously active retinal ribbon synapses and mainly consist of the RIBEYE protein. In the OCA1 patient, photoreceptor synaptic ribbons were very small and reduced to small fragments that were either still associated with the active zone transmitter release site or floating in the cytosol. The RIBEYE gene appeared to be unaltered in the OCA1 patient, except for some single nucleotide polymorphisms (SNPs) that were also present in controls. The OCA1 patients displayed similar defects of photoreceptor synaptic ribbons as previously observed in the albinotic mice with a defect in the tyrosinase gene. The observed alterations of synaptic ribbons are not due to mutations in the RIBEYE gene but are likely indirect consequences of the deficient melanin biosynthesis in the OCA1 patient.
TYROSINASE-Deficient Human Retinal Pigment Epithelium Exhibits Melanosome Maturation Defects.
Oculocutaneous albinism type 1A (OCA1A) is a rare recessive genetic condition caused by mutations in TYROSINASE (TYR) that results in pigmentation defects of the skin, hair and eyes. This study was performed to understand melanosome biogenesis and maturation defects in an OCA1A in vitro model using retinal pigment epithelium (RPE) derived from TYR knockout human induced pluripotent stem cells (iPSC). CRISPR-Cas9 was used to knockout the TYR gene in iPSC to generate an isogenic pair. A developmentally guided protocol was used to differentiate the isogenic iPSC pair towards RPE monolayer tissue. Monolayer organization, melanosome formation and maturation were studied using electron microscopy. Loss of TYR protein was studied using Western blot and immuno-fluorescence staining. RPE cellular morphology and junction integrity was studied using immunofluorescence staining and transepithelial resistance measurements. An isogenic pair comprising of untargeted control and TYR knockout iPSC were successfully differentiated towards RPE monolayer tissue with polygonal cell morphology. TYR knockout RPE exhibited significantly reduced TYR protein, increased presence of immature pre-melanosomes and a complete lack of mature melanosomes. We observed abnormal junctional localization of β-catenin staining pattern, as has been reported previously for albino mouse RPE- and OCA1A patient-derived RPE. Differentiation of TYR-deficient iPSC toward RPE displayed pigmentation defects and absence of mature melanosomes, whereas melanosome biogenesis was not affected, because pre-melanosomes were still observed. These observations were also similar to what was observed in OCA1A patient-derived RPE monolayer tissue, independently confirming the validity of these previous findings.
Publicações recentes
Quantifying functional vision in a mouse model of oculocutaneous albinism type 1.
Insights from Computational Dynamic Active Site Mapping into Substrate Recognition and Mutation-Induced Dysfunction in Human Tyrosinase.
First Report of Oculocutaneous Albinism Type I Among Baka Pygmies From Cameroon.
Generation and ophthalmological characterization of oculocutaneous albinism type 1 pig models by selection-free genome editing.
Alterations of Photoreceptor Synaptic Ribbons in the Retina of a Human Patient With Oculocutaneous Albinism Type 1 (OCA1).
📚 EuropePMC29 artigos no totalmostrando 48
Quantifying functional vision in a mouse model of oculocutaneous albinism type 1.
Scientific reportsInsights from Computational Dynamic Active Site Mapping into Substrate Recognition and Mutation-Induced Dysfunction in Human Tyrosinase.
International journal of molecular sciencesFirst Report of Oculocutaneous Albinism Type I Among Baka Pygmies From Cameroon.
Pigment cell & melanoma researchGeneration and ophthalmological characterization of oculocutaneous albinism type 1 pig models by selection-free genome editing.
Scientific reportsAlterations of Photoreceptor Synaptic Ribbons in the Retina of a Human Patient With Oculocutaneous Albinism Type 1 (OCA1).
Investigative ophthalmology & visual scienceTYROSINASE-Deficient Human Retinal Pigment Epithelium Exhibits Melanosome Maturation Defects.
Investigative ophthalmology & visual scienceRare phenotypes of white coat color in Simmental calves: genetic causes of syndromic forms of albinism and depigmentation.
Molecular genetics and genomics : MGGGenetic mutations disrupt the coordinated mode of tyrosinase's intra-melanosomal domain.
Protein science : a publication of the Protein SocietyGenetic mutations disrupt the coordinated mode of tyrosinase intra-melanosomal domain.
bioRxiv : the preprint server for biologyMultiplexed Assays of Variant Effect and Reclassification of TYR Variants in Chinese Patients with Oculocutaneous Albinism.
The Journal of investigative dermatologyArcuate pattern of retinal ganglion cell axons in oculocutaneous albinism has implications for axon pathfinding.
BMJ case reportsHuman recombinant tyrosinase destabilization caused by the double mutation R217Q/R402Q.
Protein science : a publication of the Protein SocietyA 65 kilobase deletion of the upstream TYR gene region in a family with oculocutaneous albinism type 1.
GeneAlbinism and Blood Cell Profile: The Peculiar Case of Asinara Donkeys.
Animals : an open access journal from MDPIAltered Functional Responses of the Retina in B6 Albino Tyrc/c Mice.
Investigative ophthalmology & visual scienceAfter an initial Hermansky-Pudlak syndrome clinical diagnosis, molecular testing reveals variants for oculocutaneous albinism type 1B: A case report.
Molecular genetics & genomic medicineGenotypic spectrum of albinism in Mali.
Pigment cell & melanoma researchGeneration and characterization of retinal pigment epithelium from patient iPSC line to model oculocutaneous albinism (OCA)1A disease.
Journal of biosciencesVisual acuity improvement in children with albinism beyond the first decade of life.
PloS oneReduction of lens size in PAX6-related aniridia.
Experimental eye researchEvaluating the Cysteine-Rich and Catalytic Subdomains of Human Tyrosinase and OCA1-Related Mutants Using 1 μs Molecular Dynamics Simulation.
International journal of molecular sciencesIdentification and characterization of the compound heterozygous variants of TYR gene in a northern Chinese family with Oculocutaneous albinism type 1.
Pigment cell & melanoma researchNGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.
BMC genomicsIdentification and characterization of two novel noncoding tyrosinase (TYR) gene variants leading to oculocutaneous albinism type 1.
The Journal of biological chemistryThe Phenotypic and Mutational Spectrum of the FHONDA Syndrome and Oculocutaneous Albinism: Similarities and Differences.
Investigative ophthalmology & visual scienceEvidence that the Ser192Tyr/Arg402Gln in cis Tyrosinase gene haplotype is a disease-causing allele in oculocutaneous albinism type 1B (OCA1B).
NPJ genomic medicineIn vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium.
Stem cell reportsCharacterization of Temperature-Dependent Kinetics of Oculocutaneous Albinism-Causing Mutants of Tyrosinase.
International journal of molecular sciencesDoes Early Glasses Wear Improve Visual Outcome in OCA1A?
Journal of binocular vision and ocular motilityFunctional in silico analysis of human tyrosinase and OCA1 associated mutations.
Journal of analytical & pharmaceutical researchThe structure and function of the mouse tyrosinase locus.
Pigment cell & melanoma researchA genome-wide scan study identifies a single nucleotide substitution in the tyrosinase gene associated with white coat colour in a red deer (Cervus elaphus) population.
BMC geneticsModeling human point mutation diseases in Xenopus tropicalis with a modified CRISPR/Cas9 system.
FASEB journal : official publication of the Federation of American Societies for Experimental BiologyMild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the TYR gene.
The British journal of ophthalmologyThe Molecular Basis of Chemical Chaperone Therapy for Oculocutaneous Albinism Type 1A.
The Journal of investigative dermatologyMembrane-associated human tyrosinase is an enzymatically active monomeric glycoprotein.
PloS oneNystagmus and Platinum Hair.
JAMADynamic analysis of human tyrosinase intra-melanosomal domain and mutant variants to further understand oculocutaneous albinism type 1.
Journal of analytical & pharmaceutical researchThe consequences of deglycosylation of recombinant intra-melanosomal domain of human tyrosinase.
Biological chemistryPurification of Recombinant Human Tyrosinase from Insect Larvae Infected with the Baculovirus Vector.
Current protocols in protein scienceIdentification and characterization of the tyrosinase gene (TYR) and its transcript variants (TYR_1 and TYR_2) in the crab-eating macaque (Macaca fascicularis).
GeneComputational analysis of histidine mutations on the structural stability of human tyrosinases leading to albinism insurgence.
Molecular bioSystemsProgressive retinal degeneration in a girl with Knobloch syndrome who presented with signs of ocular albinism.
Documenta ophthalmologica. Advances in ophthalmologyIdentification of a missense mutation in the tyrosinase gene in a Chinese family with oculocutaneous albinism type 1.
Molecular medicine reportsA cross-sectional examination of visual acuity by specific type of albinism.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and StrabismusOculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.
Pigment cell & melanoma researchFunctional assessment of tyrosinase variants identified in individuals with albinism is essential for unequivocal determination of genotype-to-phenotype correlation.
The British journal of dermatologyThe albinism of the feral Asinara white donkeys (Equus asinus) is determined by a missense mutation in a highly conserved position of the tyrosinase (TYR) gene deduced protein.
Animal geneticsAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Albinismo oculocutâneo tipo 1.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Albinismo oculocutâneo tipo 1
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Insights from Computational Dynamic Active Site Mapping into Substrate Recognition and Mutation-Induced Dysfunction in Human Tyrosinase.
- First Report of Oculocutaneous Albinism Type I Among Baka Pygmies From Cameroon.
- Quantifying functional vision in a mouse model of oculocutaneous albinism type 1.
- Alterations of Photoreceptor Synaptic Ribbons in the Retina of a Human Patient With Oculocutaneous Albinism Type 1 (OCA1).
- TYROSINASE-Deficient Human Retinal Pigment Epithelium Exhibits Melanosome Maturation Defects.
- Generation and ophthalmological characterization of oculocutaneous albinism type 1 pig models by selection-free genome editing.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:352731(Orphanet)
- MONDO:0018135(MONDO)
- GARD:4037(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Q1401065(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
